Tag #Kratom

Showing 1 to 4 of 4 results

forbes.com

🌐 85% Global Worthiness

Aug 19, 22:17

FDA Seeks Emergency Ban of Kratom Alkaloid 7-OH

The FDA urgently requested the DEA to classify 7-hydroxymitragynine (7-OH), a kratom alkaloid, as a Schedule I controlled substance due to concerns over potential abuse, despite limited data and the compound's potential medicinal benefits; the DEA will decide whether to immediately ban it or undergo...

FDA Seeks Emergency Ban of Kratom Alkaloid 7-OH

The FDA urgently requested the DEA to classify 7-hydroxymitragynine (7-OH), a kratom alkaloid, as a Schedule I controlled substance due to concerns over potential abuse, despite limited data and the compound's potential medicinal benefits; the DEA will decide whether to immediately ban it or undergo...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of the FDA's request to schedule 7-OH as a Schedule I controlled substance?

The FDA requested the DEA to classify 7-OH, a kratom alkaloid, as a Schedule I controlled substance due to concerns about its potential for abuse and addiction. This action follows anecdotal reports of misuse and 7-OH's binding to mu opioid receptors. A final decision is pending, but a ban could impact kratom sales and access for those using it for pain management or harm reduction.

foxnews.com

🌐 85% Global Worthiness

Aug 7, 16:18

Herbal Supplement 'Feel Free' Sparks Health Concerns, Addiction Reports

Feel Free, a kratom and kava-based supplement sold in U.S. gas stations and retailers, is causing severe health issues, including addiction, skin damage, seizures, and suicidal thoughts, prompting concerns about its unregulated nature and lack of warnings.

Herbal Supplement 'Feel Free' Sparks Health Concerns, Addiction Reports

Feel Free, a kratom and kava-based supplement sold in U.S. gas stations and retailers, is causing severe health issues, including addiction, skin damage, seizures, and suicidal thoughts, prompting concerns about its unregulated nature and lack of warnings.

Progress

68% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate health risks and consequences associated with the use of Feel Free, and how significant is its impact on users' lives?

Feel Free, a herbal supplement sold across the U.S., is raising concerns due to reported addictive properties and severe health consequences. Users describe symptoms including skin infections, seizures, suicidal thoughts, and intense withdrawal, leading to hospitalizations and substantial financial burdens, with some spending \$3,000 monthly.

dailymail.co.uk

🌐 90% Global Worthiness

Aug 17, 07:15

Florida Bans Potent Kratom Extract 7-OH Amid Opioid Crisis Fears

The FDA and Florida are taking action against 7-OH, a concentrated kratom extract estimated to be 10 to 13 times stronger than morphine, due to its opioid-like effects and potential to cause a new opioid crisis; at least one death has been attributed to 7-OH.

Florida Bans Potent Kratom Extract 7-OH Amid Opioid Crisis Fears

The FDA and Florida are taking action against 7-OH, a concentrated kratom extract estimated to be 10 to 13 times stronger than morphine, due to its opioid-like effects and potential to cause a new opioid crisis; at least one death has been attributed to 7-OH.

Progress

68% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the current regulations and enforcement of 7-OH sales contribute to the public health risk?

Concentrated 7-OH, found in vape shops and gas stations, poses a significant public health threat because of its high potency and addictive nature. The lack of federal age restrictions and inconsistent state regulations exacerbate the problem, mirroring the initial stages of the opioid epidemic. At least one death has been linked to 7-OH.

forbes.com

🌐 85% Global Worthiness

Jul 29, 22:16

FDA Recommends Ban on Kratom Byproduct 7-OH Amidst Overdose Concerns

The FDA recommends banning 7-hydroxymitragynine (7-OH), a concentrated kratom byproduct with morphine-like effects, due to a rise in overdoses and unregulated sales at gas stations and vape shops, posing significant public health risks.

FDA Recommends Ban on Kratom Byproduct 7-OH Amidst Overdose Concerns

The FDA recommends banning 7-hydroxymitragynine (7-OH), a concentrated kratom byproduct with morphine-like effects, due to a rise in overdoses and unregulated sales at gas stations and vape shops, posing significant public health risks.

Progress

56% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

How does the uncontrolled distribution and marketing of 7-OH products contribute to the potential public health crisis identified by the FDA?

The FDA's recommendation stems from a rise in overdoses and emergency room visits linked to 7-OH-containing products. The lack of quality control, dosage control, and warnings on these products, often marketed deceptively, contributes to this public health concern, impacting vulnerable populations like young people and veterans.

Showing 1 to 4 of 4 results